Cargando…

Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010077/ https://www.ncbi.nlm.nih.gov/pubmed/29533107 http://dx.doi.org/10.1080/14756366.2018.1446394

Ejemplares similares

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2017)

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019)

Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
por: Maciejewska, Karolina, et al.
Publicado: (2022)

New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023)

Correction to: Ma et al., Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy
Publicado: (2018)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2020)

Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics [Corrigendum]
Publicado: (2022)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Correction to ‘Improved nearest-neighbor parameters for the stability of RNA/DNA hybrids under a physiological condition’
por: Banerjee, Dipanwita, et al.
Publicado: (2021)

New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2023)

Fabrication of Nonfouling, Bactericidal, and Bacteria Corpse Release Multifunctional Surface Through Surface-Initiated RAFT Polymerization [Corrigendum]
Publicado: (2022)

Correction to ‘Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue’
por: Gyllborg, Daniel, et al.
Publicado: (2021)

Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease”
por: Martín-Maestro, Patricia, et al.
Publicado: (2021)

Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visual and enhanced photothermal therapy [Corrigendum]
Publicado: (2019)

A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer [Corrigendum]
Publicado: (2021)

PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]
Publicado: (2023)

Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials
por: Jimenez-Maggiora, Gustavo A, et al.
Publicado: (2022)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease
por: Hu, Xiaoqin, et al.
Publicado: (2018)

Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease
Publicado: (2019)

Multifunctional Nanosnowflakes for T1-T2 Double-Contrast Enhanced MRI and PAI Guided Oxygen Self-Supplementing Effective Anti-Tumor Therapy [Corrigendum]
Publicado: (2023)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Corrigendum to: Aortic flow is associated with aging and exercise capacity
Publicado: (2023)

Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease
por: Zhou, Yi, et al.
Publicado: (2023)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

VCPA: genomic variant calling pipeline and data management tool for Alzheimer’s Disease Sequencing Project
por: Leung, Yuk Yee, et al.
Publicado: (2019)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Publicado: (2021)

Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity
por: Tittarelli, A, et al.
Publicado: (2016)

Corrigendum to “Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges” [Redox Biol. 63 (2023) 102734]
por: Han, Ying, et al.
Publicado: (2023)

Correction to: Ocean warming favours a northern Argyrosomus species over its southern congener, whereas preliminary metabolic evidence suggests that hybridization may promote their adaptation
Publicado: (2023)

Corrigendum to “Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease”
por: Luchena, Celia, et al.
Publicado: (2019)

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease
por: Lambert, J-C, et al.
Publicado: (2013)

Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]
Publicado: (2023)

Corrigendum to: the Sussex-Waterloo Scale of Hypnotizability (SWASH): measuring capacity for altering conscious experience
por: Lush, P, et al.
Publicado: (2021)

Correction
Publicado: (2020)

Patient satisfaction with cardiac rehabilitation: association with utilization, functional capacity, and heart-health behaviors [Corrigendum]
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7t80jrf4bbt77u06v3i7g8r1us